Publication Name	World Journal of Experimental Medicine
Manuscript ID	13248
Country	Italy

Received	2014-08-13 18:19
Peer-Review Started	2014-08-14 15:19
To Make the First Decision	2014-09-28 13:57
Return for Revision	2014-09-29 19:27
Revised	2014-10-30 21:32
Second Decision	2014-11-12 14:01
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-11-19 11:25
Articles in Press	2014-11-19 11:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-01-19 13:59
Publish the Manuscript Online	2015-01-20 21:05

ISSN	2220-315x (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Research & Experimental Medicine
Manuscript Type	Review
Article Title	Consolidated and emerging inflammatory markers in coronary artery disease
Manuscript Source	Invited Manuscript
All Author List	Valter Lubrano and Silvana Balzan
Funding Agency and Grant Number
Corresponding Author	Dr. Valter Lubrano, Fondazione G. Monasterio CNR-Regione Toscana, Via Moruzzi n° 1, 56124 Pisa, Italy. walterl@ifc.cnr.it
Key Words	Coronary artery disease; Plaque instability; Inflammation; Acute phase; Biomarkers
Core Tip	In this review we want to focus the reader’s attention on the differences between inflammatory markers of cardiovascular risk already accepted by the scientific community and the emerging markers in order to encourage the healthcare services to improve laboratory techniques in early diagnosis and more precise evaluation of the risk. Is also important to use a classification according to the stage where the patient is located regarding emerging inflammatory markers for diagnosis, prognosis and plaque instability.
Publish Date	2015-01-20 21:05
Citation	Lubrano V, Balzan S. Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med 2015; 5(1): 21-32
URL	http://www.wjgnet.com/2220-315X/full/v5/i1/21.htm
DOI	http://dx.doi.org/10.5493/wjem.v5.i1.21

Full Article (PDF)	WJEM-5-21.pdf
Full Article (Word)	WJEM-5-21.doc
Manuscript File	13248-Review.docx
Answering Reviewers	13248-Answering reviewers.pdf
Copyright License Agreement	13248-Copyright assignment.pdf
Peer-review Report	13248-Peer review(s).pdf
Scientific Misconduct Check	13248-CrossCheck.jpg
Scientific Editor Work List	13248-Scientific editor work list.pdf